MTFB

MOTIF BIO PLC ORD 0.01P

TitleTime
Holding(s) in CompanyThu 21/05/20 | 12:20
Holding(s) in CompanyTue 19/05/20 | 10:30
Exercise of WarrantsFri 15/05/20 | 07:00
Holding(s) in CompanyTue 12/05/20 | 17:02
Placing to raise £650,000Tue 05/05/20 | 07:00
Second Price Monitoring ExtnMon 04/05/20 | 16:41
Price Monitoring ExtensionMon 04/05/20 | 16:36
Directorate Changes & Corporate UpdateMon 04/05/20 | 07:00
Second Price Monitoring ExtnWed 15/04/20 | 16:41
Price Monitoring ExtensionWed 15/04/20 | 16:36
Second Price Monitoring ExtnTue 14/04/20 | 16:41
Price Monitoring ExtensionTue 14/04/20 | 16:37
Stmnt re Share Price MovementTue 14/04/20 | 13:21
Second Price Monitoring ExtnThu 09/04/20 | 16:40
Price Monitoring ExtensionThu 09/04/20 | 16:36
Second Price Monitoring ExtnThu 09/04/20 | 12:08
Price Monitoring ExtensionThu 09/04/20 | 12:03
Second Price Monitoring ExtnTue 07/04/20 | 16:41
Price Monitoring ExtensionTue 07/04/20 | 16:36
Motif BioThu 19/03/20 | 17:30
Second Price Monitoring ExtnThu 19/03/20 | 16:43
Price Monitoring ExtensionThu 19/03/20 | 16:39
Corporate UpdateWed 18/03/20 | 07:00
Second Price Monitoring ExtnThu 12/03/20 | 16:42
Price Monitoring ExtensionThu 12/03/20 | 16:36
Price Monitoring ExtensionThu 12/03/20 | 12:02
Price Monitoring ExtensionFri 07/02/20 | 16:35
Second Price Monitoring ExtnTue 28/01/20 | 16:40
Price Monitoring ExtensionTue 28/01/20 | 16:35
Corporate UpdateTue 28/01/20 | 07:00
Second Price Monitoring ExtnWed 22/01/20 | 16:40
Price Monitoring ExtensionWed 22/01/20 | 16:35
Holding(s) in CompanyFri 17/01/20 | 12:12
Second Price Monitoring ExtnThu 16/01/20 | 16:41
Price Monitoring ExtensionThu 16/01/20 | 16:35
Second Price Monitoring ExtnThu 16/01/20 | 12:07
Price Monitoring ExtensionThu 16/01/20 | 12:02
Holding(s) in CompanyTue 14/01/20 | 12:35
Holding(s) in CompanyFri 10/01/20 | 09:55
Second Price Monitoring ExtnMon 06/01/20 | 16:40
Price Monitoring ExtensionMon 06/01/20 | 16:35
Holding(s) in CompanyFri 03/01/20 | 10:42
Holding(s) in CompanyMon 23/12/19 | 09:45
Holding(s) in CompanyThu 19/12/19 | 16:29
Holding(s) in CompanyThu 19/12/19 | 16:25
Voluntary delisting from the NASDAQ Capital MarketTue 10/12/19 | 07:00
Holding(s) in CompanyFri 06/12/19 | 11:14
Holding(s) in CompanyFri 29/11/19 | 12:20
Total Voting RightsFri 29/11/19 | 07:00
ADS Program and Warrant Agent AgreementWed 27/11/19 | 07:00
Voluntary Delisting from the Nasdaq Capital MarketTue 26/11/19 | 07:00
Holding(s) in CompanyWed 20/11/19 | 17:51
Directorate ChangesMon 18/11/19 | 12:12
Result of General MeetingThu 14/11/19 | 18:13
Settlement AgreementMon 11/11/19 | 07:00
Holding(s) in CompanyMon 28/10/19 | 16:14
Holding(s) in CompanyFri 25/10/19 | 15:51
Second Price Monitoring ExtnFri 25/10/19 | 12:07
Price Monitoring ExtensionFri 25/10/19 | 12:02
Posting of Circular and Notice of General MeetingFri 25/10/19 | 07:00
U.S. Army-funded project to Evaluate IclaprimThu 24/10/19 | 07:00
Timing of General Meeting and CircularMon 21/10/19 | 15:00
Second Price Monitoring ExtnMon 21/10/19 | 12:07
Price Monitoring ExtensionMon 21/10/19 | 12:02
Motif Bio confirms receipt of FDA meeting minutesThu 10/10/19 | 07:00
Second Price Monitoring ExtnThu 03/10/19 | 12:07
Price Monitoring ExtensionThu 03/10/19 | 12:02
Change of AdviserThu 03/10/19 | 07:00
Conditional PlacingWed 02/10/19 | 07:00
Second Price Monitoring ExtnMon 30/09/19 | 16:40
Price Monitoring ExtensionMon 30/09/19 | 16:35
Half-year ReportMon 30/09/19 | 14:22
Second Price Monitoring ExtnTue 17/09/19 | 16:41
Price Monitoring ExtensionTue 17/09/19 | 16:35
Holding(s) in CompanyWed 04/09/19 | 14:57
Amended Loan and Security AgreementMon 02/09/19 | 07:00
Second Price Monitoring ExtnFri 30/08/19 | 16:41
Price Monitoring ExtensionFri 30/08/19 | 16:35
Amended Loan and Security AgreementThu 01/08/19 | 07:00
Motif Bio Confirms Meeting Date with U.S. FDAFri 26/07/19 | 07:00
Receipt of Deficiency Notice from NasdaqFri 26/07/19 | 07:00
Motif Bio-Receipt of Deficiency Notice from NasdaqFri 19/07/19 | 07:00
Holding(s) in CompanyThu 18/07/19 | 16:30
US FDA meeting request and package submittedMon 15/07/19 | 07:00
Holding(s) in CompanyFri 28/06/19 | 17:13
Second Price Monitoring ExtnFri 28/06/19 | 16:40
Price Monitoring ExtensionFri 28/06/19 | 16:36
Second Price Monitoring ExtnWed 26/06/19 | 12:07
Price Monitoring ExtensionWed 26/06/19 | 12:02
Price Monitoring ExtensionThu 20/06/19 | 16:35
Holding(s) in CompanyWed 19/06/19 | 17:08
Holding(s) in CompanyTue 18/06/19 | 16:05
Holding(s) in CompanyFri 14/06/19 | 09:04
Holding(s) in CompanyWed 12/06/19 | 17:52
Receipt of FDA Meeting MinutesThu 06/06/19 | 07:00
Result of AGMFri 31/05/19 | 15:15
Holding(s) in CompanyFri 31/05/19 | 10:28
Holding(s) in CompanyWed 29/05/19 | 11:36
AGM StatementWed 22/05/19 | 13:50
Holding(s) in CompanyMon 20/05/19 | 18:14
Notice of AGMFri 26/04/19 | 07:01
Appointment of Andrew Powell to Board of DirectorsFri 26/04/19 | 07:00
Fiscal Year 2018 ResultsMon 15/04/19 | 07:00
Holding(s) in CompanyTue 02/04/19 | 17:43
Holding(s) in CompanyMon 01/04/19 | 15:28
Holding(s) in CompanyMon 01/04/19 | 14:17
Motif Bio Raises £2.7m (US$3.55m)Tue 26/03/19 | 07:00
Proposed Equity FundraiseMon 25/03/19 | 09:49
Holding(s) in CompanyWed 20/03/19 | 07:00
Motif Bio Granted Meeting with U.S. FDAWed 20/03/19 | 07:00
Appointment of Bruce Williams as Interim ChairmanMon 18/03/19 | 07:00
Holding(s) in CompanyFri 15/03/19 | 07:01
Second Price Monitoring ExtnThu 07/03/19 | 12:07
Price Monitoring ExtensionThu 07/03/19 | 12:02
Conference Call and WebcastTue 19/02/19 | 07:00
Amendment Agreement with Hercules CapitalMon 18/02/19 | 07:00
Holding(s) in CompanyFri 15/02/19 | 16:28
Holding(s) in CompanyFri 15/02/19 | 16:26
Complete Response Letter from the FDAThu 14/02/19 | 07:00
Exercise of WarrantsTue 05/02/19 | 07:00
Exercise of WarrantsWed 23/01/19 | 16:31
Second Price Monitoring ExtnThu 01/11/18 | 16:40
Price Monitoring ExtensionThu 01/11/18 | 16:35
Price Monitoring ExtensionTue 30/10/18 | 16:35
Second Price Monitoring ExtnTue 16/10/18 | 16:40
Price Monitoring ExtensionTue 16/10/18 | 16:35
Motif Bio Notes Statement from Amphion InnovationsFri 28/09/18 | 07:01
Half-year ReportTue 25/09/18 | 07:00
Price Monitoring ExtensionWed 29/08/18 | 16:35
Motif Bio notes statement from Amphion InnovationsTue 21/08/18 | 07:15
Holding(s) in CompanyTue 14/08/18 | 16:49
Holding(s) in CompanyTue 14/08/18 | 16:48
FDA Acceptance of New Drug ApplicationTue 14/08/18 | 07:00
Notice of Allowance for Two U.S. Iclaprim PatentsWed 08/08/18 | 07:00
Price Monitoring ExtensionThu 02/08/18 | 16:35
Holding(s) in CompanyTue 03/07/18 | 16:48
Directorate ChangeTue 03/07/18 | 07:00
Exercise of Stock OptionsTue 26/06/18 | 11:57
Result of AGMTue 19/06/18 | 13:58
Motif Bio Submits NDA for IclaprimThu 14/06/18 | 07:00
Holding(s) in CompanyMon 11/06/18 | 11:41
Holding(s) in CompanyFri 08/06/18 | 17:08
Holding(s) in CompanyFri 25/05/18 | 16:04
Holding(s) in CompanyThu 24/05/18 | 16:39
Holding(s) in CompanyWed 23/05/18 | 17:42
Motif Bio notes statement from Amphion InnovationsWed 23/05/18 | 07:00
Result of PlacingThu 17/05/18 | 14:24
Proposed Placing to raise approximately £10mThu 17/05/18 | 09:55
Second Price Monitoring ExtnTue 17/04/18 | 16:40
Price Monitoring ExtensionTue 17/04/18 | 16:35
Posting of UK Annual Report and Notice of AGMTue 17/04/18 | 07:00
Fiscal Year 2017 ResultsTue 10/04/18 | 07:00
Holding(s) in CompanyTue 03/04/18 | 15:29
Initiation of NDA Rolling Submission for IclaprimTue 03/04/18 | 07:00
Motif Bio Update on NDA Submission for IclaprimTue 20/03/18 | 07:00
Change of Registered OfficeTue 13/03/18 | 15:55
Exercise of WarrantsWed 07/03/18 | 12:29
Grant of share options to senior managementThu 01/03/18 | 07:00
Exercise of WarrantsMon 19/02/18 | 12:53
Appointment of Interim Chief Financial OfficerFri 02/02/18 | 15:00
Second Price Monitoring ExtnMon 29/01/18 | 12:07
Price Monitoring ExtensionMon 29/01/18 | 12:02
Filing of U.S. Shelf RegistrationFri 19/01/18 | 07:00
Motif Bio Receives Award from CF FoundationTue 16/01/18 | 07:00
Holding(s) in CompanyFri 12/01/18 | 15:12
Holding(s) in CompanyThu 11/01/18 | 15:07
Exercise of WarrantsMon 08/01/18 | 15:23
Notes statement from Amphion InnovationsFri 22/12/17 | 07:01
Holding(s) in CompanyTue 28/11/17 | 18:24
Exercise of WarrantsFri 17/11/17 | 07:00
Holding(s) in CompanyFri 17/11/17 | 07:00
Secures up to US$20 million debt financingWed 15/11/17 | 07:00
Exercise of WarrantsThu 09/11/17 | 14:40
Holding(s) in CompanyMon 06/11/17 | 12:29
Holding(s) in CompanyWed 18/10/17 | 07:00
Holding(s) in CompanyFri 06/10/17 | 13:20
Holding(s) in CompanyThu 05/10/17 | 09:57
Positive Topline Results in Phase Three StudyWed 04/10/17 | 07:00
Half-year ReportFri 29/09/17 | 07:00
Holding(s) in CompanyMon 25/09/17 | 07:01
iclaprim granted Orphan Drug Designation by US FDAFri 15/09/17 | 14:07
Holding(s) in CompanyWed 30/08/17 | 07:00
REVIVE 2 Trial Last Patient TreatedWed 09/08/17 | 07:00
Amendment to Amphion Consultancy AgreementTue 18/07/17 | 07:00
Exercise of warrantsWed 28/06/17 | 12:41
Holding(s) in CompanyTue 27/06/17 | 07:00
Result of General MeetingThu 22/06/17 | 15:20
Results of Annual General MeetingThu 15/06/17 | 17:42